{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"15.0","upperLimit":"20.0","value":"17"},{"groupId":"OG001","lowerLimit":"17","upperLimit":"19","value":"18"},{"groupId":"OG002","lowerLimit":"17","upperLimit":"18","value":"17"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"77"},{"groupId":"OG002","value":"37"}],"units":"Participants"}],"description":"Time to platelet engraftment, after auto-HCT, where engraftment was defined as the first of 3 consecutive measurements of platelet count ≥20 × 10\\^9/L without platelet transfusion support for 7 days following the conditioning regimen associated nadir.","dispersionType":"95% Confidence Interval","groups":[{"description":"Part 1 (lead-in) period. G-CSF given one time daily s.c. for 5-8 days (Days 1 up to 8) at doses of approximately 10 µg/kg/day but not more than 15 µg/kg/day. BL-8040 1.25 mg/kg s.c. on Day 4 (and Day 6, if needed).\n\nFirst apheresis on Day 5 with up to 3 additional procedures possible until Day 8, as needed","id":"OG000","title":"BL-8040 + G-CSF Part 1"},{"description":"Part 2: randomized, double-blinded, placebo-controlled period. G-CSF given one time daily s.c. for 5-8 days (Day 1 up to 8) at doses of approximately 10 µg/kg/day but not more than 15 µg/kg/day. BL-8040 1.25 mg/kg s.c. on Day 4 (and Day 6, if needed).\n\nFirst apheresis on Day 5 with up to 3 additional procedures possible until Day 8, as needed.","id":"OG001","title":"BL-8040 + G-CSF Part 2"},{"description":"Part 2: randomized, double-blinded, placebo-controlled period. G-CSF given one time daily s.c. for 5-8 days (Day 1 up to 8) at doses of approximately 10 µg/kg/day but not more than 15 µg/kg/day. Placebo s.c. on Day 4 (and Day 6, if needed).\n\nFirst apheresis on Day 5 with up to 3 additional procedures possible until Day 8, as needed.","id":"OG002","title":"Placebo + G-CSF Part 2"}],"paramType":"MEDIAN","populationDescription":"Post Transplantation analysis set (all subjects treated, with at least 1 apheresis session, and who underwent transplantation)","reportingStatus":"POSTED","timeFrame":"End of engraftment period, which was defined as 29 days post transplantation","title":"Time to Platelet Engraftment, After Auto-HCT","type":"SECONDARY","unitOfMeasure":"Point estimate (days)"}